Related to this topic: Leaflets | Support | Patient+ | UK Guidelines | Online Videos | News | Weblinks | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Bone Marrow and Bone Marrow Failure

Bone marrow consists of a matrix of sinusoids lined with epithelial cells interspersed with islands of erythropoietic cells encapsulated by reticulin cells.1 The bone marrow weighs about 3000 g in an average adult male. It is composed of active red marrow 50% and inactive adipose tissue (yellow marrow) 50%. Half of the red marrow is itself adipose tissue, so the total amount of active red marrow in the body is 25% of the total mass.2

Bone marrow is mainly found in the pelvis, ribs and ends of long bones of arms and legs. At birth, 100% of marrow is of the active red type, and this is gradually replaced by adipose tissue as the individual ages.3

Some erythropoietic cells are stem cells. Pluripotent stem cells are able to both renew themselves and differentiate into various cell types, depending upon the growth factors acting upon them. They first differentiate into either lymphoid stem cells or a myeloid stem cells.4 Lymphoid stem cells can only develop into B-, T- or NK lymphocytes. Myeloid stem cells undergo a series of stages as progenitor and precursor cells to form erythrocytes, platelets (via megakaryocytes), basophils, polymorphonuclear leucocytes, monocytes/macrophages and eosinophils.5 Growth factors that determine this differentiation include erythropoietin and granulocyte colony-stimulating factor.6

Bone marrow failure7

Bone marrow failure can either affect red blood cells (RBCs,) white blood cells (WBCs ) and platelets (in which case the condition is termed pancytopenia) or single cell line deficiencies can occur.

Pancytopaenia

Bone marrow problems causing this include:

Single cell line deficiencies are rare. They include:

Epidemiology7

Aplastic anaemia is rare in Europe (~2/million population) but bone marrow failure from leukaemia (~30/million population) or myelodysplasia (~50/million population) is far more common. Bone marrow failure is also a frequent side effect of radiotherapy and chemotherapy.9

Presentation7

Whatever the cause, patient presents with signs and symptoms of:

  • Anaemia - tiredness, weakness, pallor, breathlessness, tachycardia
  • Neutropenia - recurrent or severe bacterial infections
  • Thrombocytopenia - easy bruising, petechiae, bleeding from nose and/or gums

Presence of hepatomegaly, splenomegaly or lymphadenopathy suggests a diagnosis of leukaemia.

Differential diagnosis7
Investigations
  • Full blood count - normocytic, normochromic anaemia with low reticulocyte count in aplastic anaemia and myelodysplasia.
  • White cell count - indicates whether leukaemia or megaloblastic anaemia is cause
  • Bone marrow aspiration and biopsy - hypoplastic in non-leukaemic cause, histology may give indication of cause of failure
Management

Non-drug

  • Transfusions with packed red cells and platelets may be required, severe cases may require bone marrow transplantation.10
  • Children with severe aplastic anaemia are now being treated with matched-related donor stem cell transplantation (or unrelated, if no family match is possible).11
Drugs
  • Antibiotics may be needed if there is infection.
  • Antithymocyte globulin and antilymphocyte globulin with oxymethalone and high dose IV methylprednisolone is a beneficial regime for a significant number of aplastic anaemia patients.12
  • Other drugs used which have been used in aplastic anaemia with haemopoietic growth factors, and antithymocyte globulin include danazol and ciclosporin.13
  • Myelodysplasia can be treated with supportive transfusion and treatment of infection whilst a search is made for an allogeneic stem cell donor. Intensive chemotherapy regimes are not usually successful.

Document references
  1. Kopp HG, Avecilla ST, Hooper AT, et al; The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda). 2005 Oct;20:349-56. [abstract]
  2. Dass, C Parker J; Joint Program in Nuclear Medicine Bone Marrow Scintigraphy Harvard Medical School 1997
  3. Ricci C, Cova M, Kang YS, et al; Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology. 1990 Oct;177(1):83-8. [abstract]
  4. Reya T; Regulation of hematopoietic stem cell self-renewal. Recent Prog Horm Res. 2003;58:283-95. [abstract]
  5. Stem Cell Basics; Stem Cell Information US National Institutes of Health 2007
  6. Olweus J, Terstappen LW, Thompson PA, et al; Expression and function of receptors for stem cell factor and erythropoietin during lineage commitment of human hematopoietic progenitor cells. Blood. 1996 Sep 1;88(5):1594-607. [abstract]
  7. Besa E, Woermann, U; Bone Marrow Failure eMedicine.com
  8. Wiholm BE, Kelly JP, Kaufman D, et al; Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies. BMJ. 1998 Feb 28;316(7132):666.
  9. Lee D; Causes of Bone Marrow Failure Faculty of Health Sciences Queens School of Medicine, Ca 2007
  10. Vassiliou GS, Webb DK, Pamphilon D, et al; Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath. Br J Haematol. 2001 Sep;114(3):701-5. [abstract]
  11. Kennedy-Nasser AA, Leung KS, Mahajan A, et al; Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant. 2006 Dec;12(12):1277-84. [abstract]
  12. Kulkarni S, Sastry PS, Saikia TK, et al; Antilymphocyte globulin (ALG) or antithymocyte globulin (ATG) with methylprednisone and oxymethalone in aplastic anaemia. J Assoc Physicians India. 1997 Apr;45(4):263-6. [abstract]
  13. Kojima S, Hibi S, Kosaka Y, et al; Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood. 2000 Sep 15;96(6):2049-54. [abstract]
Acknowledgements EMIS is grateful to Dr Laurence Knott for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2008.
DocID: 1877
Document Version: 21
DocRef: bgp1054
Last Updated: 17 Oct 2007
Review Date: 16 Oct 2009

Patient Experience




















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site










Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page